RIZMOIC 200 micrograms, film-coated tablet 30 tablets, CIP 3400930278406
Active ingredients: NALDÉMÉDINE, TOSYLATE DE NALDÉMÉDINE
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930278406orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RIZMOIC 200 microgrammes, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- SHIONOGI (PAYS BAS)
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 25 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66266368CIP73027840CIP133400930278406Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOSYLATE DE NALDÉMÉDINEcomprimé | — | SA |
| NALDÉMÉDINEcomprimé | 200 microgrammes · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.